Company / Current Liabilities
Stoke Therapeutics, Inc. Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$57.9M
FY2025
5-year range
$17.1M / $57.9M
FY2021-FY2025
Trend
+44.5%
vs FY2024
Sector context
#135 of 213
Health Care
What the data says
At $58M, Stoke Therapeutics, Inc.'s current liabilities ranks #79 of 213 in the Health Care sector. Increased from $31M to $58M over the past 2 years.
Based on SEC 10-K filings.
$58M in FY2025 with a 5-year CAGR of +38.3%.
Increased from $31M to $58M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +22.6%
- 5-Year CAGR
- +38.3%
- 10-Year CAGR
- -
Sector benchmark
#79 of 213 in Health CareTop 37% of 213This company $57.9M Sector average $1.6B
▼
-96.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +38.3%, indicating consistent growth.
- In FY2025, current liabilities increased 44.5% year-over-year.
- Ranks #135 out of 213 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $57.9M | +44.5% |
| FY2024 | $40.1M | +30.0% |
| FY2023 | $30.8M | -1.8% |
| FY2022 | $31.4M | +83.2% |
| FY2021 | $17.1M | +50.0% |
| FY2020 | $11.4M | +178.6% |
| FY2019 | $4.1M | +66.2% |
| FY2018 | $2.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026